Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA-modifying protein YgfZ is a conserved folate-binding protein that plays a pivotal role in the biogenesis and repair of iron-sulfur (Fe-S) clusters in bacteria and eukaryotes [1, 3]. In Escherichia coli, it is specifically required for the maturation of [4Fe-4S] clusters in radical S-adenosylmethionine (SAM) enzymes, such as MiaB and RimO, which catalyze essential modifications of tRNA and ribosomal proteins [8, 26]. YgfZ also functions as a regulator of chromosomal replication initiation by modulating the levels of ATP-DnaA and participates in the cellular response to oxidative stress [9, 18]. The human ortholog, IBA57, is a critical mitochondrial assembly factor, and its deficiency leads to severe neurodegenerative and metabolic conditions, including Multiple Mitochondrial Dysfunctions Syndrome 3 (MMDS3) [20, 23]. While YgfZ is considered a potential target for the development of new antimicrobial agents due to its role in bacterial fitness and stress resistance, its structural similarity to the human mitochondrial counterpart poses a significant challenge for achieving therapeutic selectivity [14, 27]. Current research focuses on understanding its precise mechanism of action and its interaction with other components of the Fe-S cluster assembly machinery [5, 30].
YgfZ facilitates the assembly and repair of [4Fe-4S] clusters by acting as a folate-dependent factor that likely removes deleterious one-carbon units or stabilizes cluster transfer to target enzymes like MiaB and RimO [1, 2, 5]. It interacts with the IscA/SufA scaffold proteins to promote the maturation of specific Fe-S proteins [7, 8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA-modifying protein YgfZ (YgfZ).